Researchers have successfully treated the skin diseases epidermolytic ichthyosis and ichthyosis with confetti by transplanting genetically healthy skin to inflamed areas. Their work could pave the way ...
Emerging genetic therapies targeting Autosomal Recessive Congenital Ichthyoses (ARCI) present promising market opportunities due to unmet needs and rising prevalence. Improved diagnostics and ...
In a first-of-its-kind treatment, doctors replaced 80 percent of a boy's skin. Doctors lift up a sheet of modified skin cells in the lab at St. Josef Hospital in Bochum, Germany, where experimental ...
KaDee Troop is the mother of seven adopted children, four of whom have a rare genetic disorder that causes their skin to blister and tear at the slightest touch. Wounds heal slowly — if at all — and ...
Cory Simpson, MD, PhD, assistant professor of dermatology at the University of Washington, spoke to the need for more treatment options in genetic skin conditions and the possibility of drug ...
ASHBURN, Va., June 26, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases ...
Palvella Therapeutics to begin trading on Nasdaq as "PVLA," focusing on rare genetic skin disease therapies with strong funding support. Palvella Therapeutics, a clinical-stage biopharmaceutical ...
Co-Founder and former Chief Technical Officer of Arcutis Biotherapeutics (ARQT) brings extensive topical product development experience, including track record of translating science into commercially ...
This article is part of Nature Outlook: Skin, an editorially independent supplement produced with financial support from LEO Pharma. About this content. KaDee Troop is the mother of seven adopted ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback